HPRT mutations, TCR gene rearrangements, and HTLV-1 integration sites define in vivo T-cell clonal lineages

Environmental and Molecular Mutagenesis

Volumn 45, Issue 2-3, 2005, Pages 326-337

  Allegretta, Mark ^a,b   Ardell, Stephanie K ^a,b   Sullivan, Linda M ^a   Jacobson, Steven ^c   Mortreux, Franck ^d   Wattel, Eric ^d,e   Albertini, Richard J ^a,b  

^a UNIVERSITY OF VERMONT   (United States)

^b Building C   (United States)

^c NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^d UNIVERSITÉ LYON 1   (France)

^e EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

HAM TSP; HPRT mutations; HTLV 1; T cell receptors; T lymphocytes

Indexed keywords

GENE PRODUCT; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE;

ADULT; ARTICLE; CELL CLONE; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; GENE; GENE MUTATION; GENE REARRANGEMENT; GENOMIC INSTABILITY; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE GENE; IN VIVO STUDY; MOLECULAR DYNAMICS; MOLECULAR GENETICS; MOLECULAR PROBE; MUTAGENESIS; MUTATIONAL ANALYSIS; T LYMPHOCYTE; T LYMPHOCYTE RECEPTOR GENE; VIRUS DNA CELL DNA INTERACTION;

CELL DIFFERENTIATION; CELL LINEAGE; DNA PRIMERS; FLOW CYTOMETRY; GENE REARRANGEMENT, T-LYMPHOCYTE; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; MODELS, GENETIC; MOLECULAR PROBE TECHNIQUES; MUTATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTES; VIRUS INTEGRATION;

HTLV; HUMAN T-LYMPHOTROPIC VIRUS 1;

EID: 17044396420     PISSN: 08936692     EISSN: None     Source Type: Journal    
DOI: 10.1002/em.20120     Document Type: Article

References (54)

1. Albertini RJ, Nicklas JA, Skopek TR, Redo L, O'Neill JP. 1998. Genetic instability in human T lymphocytes. Mutat Res 400:381-389.
2. Albertini RJ. 2001. HPRT mutations in humans: biomarkers for mechanistic studies. Mutat Res 489:1-16.
3. Albertini MR, King DM, Newton MA, Vacek PM. 2001. In vivo mutant frequency of thioguanine-resistant T-cells in the peripheral blood and lymph nodes of melanoma patients. Mutat Res 476:83-97.
4. Allegretta M, Nicklas JA, Sriram S, Albertini RJ. 1990. T cells responsive to myelin basic protein in patients with multiple sclerosis. Science 247:718-721.
5. Alt FW, Young F, Gorman J, Taccioli G, Chen J. 1992. VDJ recombination. Immunol Today 13:306-314.
6. -) T cells in the peripheral blood of cardiac transplant recipients: a non-invasive technique for the diagnosis of allograft rejection. Circulation 92:862.
7. Boehm T, Rabbitts TH. 1989. The human T cell receptor genes are targets for chromosomal abnormalities in T cell tumors. FASEB J 3:2344-2359.
8. Breit T, Mol EJ, Wolvers-Tettero ILM, Ludwig W-D, van Wering ER, Van Dongen JJM. 1993. Site-specified deletions involving the tal-1 and sil genes are restricted to cells of the T cell receptor lineage: T cell receptor gene deletion mechanisms affect multiple genes. J Exp Med 177:965-977.
9. Cannons JL, Karsh J, Birnboim HC, Goldstein R. 1998. HPRT-mutant T cells in the peripheral blood and synovial tissue of patients with rheumatoid arthritis. Arthritis Rheum 41:1772-1782.
10. Cavrois M, Wain-Hobson S, Wattel E. 1995. Stochastic events in the amplification of HTLV-1 integration sites by linker-mediated PCR. Res Virol 146:179-184.
11. Cavrois M, Gessain A, Wain-Hobson S, Wattel E. 1996. Proliferation of HTLV-I infected circulating cells in vivo in all asymptomatic carriers and patients with TSP/HAM. Oncogene 12:2419-2423.
12. Cavrois M, Leclercq I, Gout O, Gessain A, Wain-Hobson S, Wattel E. 1998. Persistent oligoclonal expansion of human T-cell leukemia virus type-1 infected circulating cells in patients with tropical spastic paraparesis/HTLV-I associated myelopathy. Oncogene 17:77-82.
13. Chen G, Zeng W, Green S, Young NS. 2004. Frequent HPRT mutations in paroxysmal nocturnal haemoglobinuria reflect T cell expansion, not genomic instability. Br J Haematol 125:383-391.
14. Cole J, Skopek TR. 1994. International Commission for Protection Against Environmental Mutagens and Carcinogens, working paper 3: somatic mutant frequency, mutation rates and mutational spectra in the human population in vivo. Mutat Res 304:33-106.
15. Dawisha SM, Gmelig-Meyling F, Steinberg AD. 1994. Assessment of clinical parameters associated with increased frequency of mutant T cells in patients with systemic lupus erythematosus. Arthritis Rheum 37:270-277.
16. de The G, Bomford R. 1993. An HTLV-I vaccine: why, how, for whom? AIDS Res Hum Retroviruses 9:381-386.
17. Edwards A, Voss H, Rice P, Civitello A, Stegemann J, Schwager C, Zimmermann J, Erfle H, Caskey CT, Ansorge W. 1990. Automated DNA sequencing of the human HPRT locus. Genomics 6:593-608.
18. Falta MT, Magin GK, Allegretta M, Steinman L, Atkinson MA, Brostoff SW, Albertini RJ. 1999. Selection of HPRT mutant T cells as surrogates for dividing cells reveals a restricted T cell receptor BV repertoire in insulin-dependent diabetes mellitus. Clin Immunol 90:340-351.
19. Falta MT, Atkinson MA, Allegretta M, Vacek PM, Albertini RJ. 2000. Azathioprine associated T-cell mutations in insulin-dependent diabetes mellitus. Scand J Immunol 51:626-633.
20. Finette BA, Poseno T, Albertini RJ. 1996. V(D)J recombinase-mediated HPRT mutations in peripheral blood lymphocytes of normal children. Cancer Res 56:1405-1412.
21. Finette BA, O'Neill JP, Vacek PM, Albertini RJ. 1998. Gene mutations with characteristic deletions in cord blood T lymphocytes associated with passive maternal exposure to tobacco smoke. Nat Med 4:1144-1151.
22. Finette BA, Homans AC, Albertini RJ. 2000. Emergence of genetic instability in children treated for leukemia. Science 288:514-517.
23. Finger LR, Harvey RC, Moore RCA, Showe LC, Croce CM. 1986. A common mechanism of chromosomal translocation in T and B cell neoplasia. Science 234:982-985.
24. Fuscoe JC, Zimmerman LJ, Lippert ML, Nicklas JA, O'Neill JP, Albertini RJ. 1991. V(D)J recombinase-like activity mediates HPRT gene deletion in human fetal T cells. Cancer Res 51:6001-6005.
25. Fuscoe JC, Zimmerman LJ, Harrington-Brock K, Burnette L, Moore MM, Nicklas JA, O'Neill JP, Albertini RJ. 1992. V(D)J recombinase-mediated deletion of the HPRT gene in T lymphocytes from adult humans. Mutat Res 283:13-20.
26. Fuscoe JC, Vira LK, Collard DD, Moore MM. 1997. Quantification of HPRT gene deletions mediated by illegitimate V(D)J recombination in peripheral blood cells of humans. Environ Mol Mutagen 29:28-35.
27. Gessain A, Barin F, Vernant JC, Gout O, Maurs L, Calender A, de The G. 1985. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 2:407-410.
28. Gibbs RA, Nguyen PN, McBride LJ, Koepf SM, Caskey CT. 1989. Identification of mutations leading to the Lesch-Nyhan syndrome by automated direct DNA sequencing of in vitro amplified cDNA. Proc Natl Acad Sci USA 86:1919-1923.
29. Gibbs RA, Nguyen PN, Edwards A, Civitello AB, Caskey CT. 1990. Multiplex DNA deletion detection and exon sequencing of the hypoxanthine phosphoribosyltransferase gene in Lesch-Nyhan families. Genomics 7:235-244.
30. Holyst MM, Hill DL, Sharp GAC, Hoffman RW. 1994. Increased frequency of mutations in the HPRT gene of T cells isolated from patients with anti-U1-70kD-autoantibody-positive connective tissue disease. Int Arch Allergy Immunol 105:234-237.
31. Jacobson S, Raine CS, Mingioli ES, McFarlin DE. 1988. Isolation of an HTLV-I-like retrovirus from patients with tropical spastic paraparesis. Nature 331:540-543.
32. Judice S. 2001. Human and mouse T-cell trafficking, mutation and kinetics. PhD thesis. Vermont: University of Vermont
33. Kannagi M, Matsushita S, Harada S. 1993. Expression of the target antigen for cytotoxic T-lymphocytes on adult T-cell leukemia cells. Int J Cancer 54:582-588.
34. Kaplan JE, Osame M, Kubota H, Igata A, Nishitani H, Maeda Y, Khabbaz RF, Janssen RS. 1990. The risk of development of HTLV-I-associated myelopathy/tropical spastic paraparesis among persons infected with HTLV-I. J AIDS 3:1096-1101.
35. Levin MC, Lehky TJ, Flerlage AN, Katz D, Kingma DW, Jaffe ES, Heiss JD, Patronas N, McFarland HF, Jacobson S. 1997. Immunologic analysis of a spinal cord-biopsy specimen from a patient with human T-cell lymphotropic virus type I-associated neurologic disease. N Engl J Med 336:839-845.
36. Lewis SM. 1994. The mechanism of V(D)J joining: lessons from molecular, immunological and comparative analyses. Adv Immunol 56:27-150.
37. Loeb LA. 2001. A mutator phenotype in cancer. Cancer Res 61:3230-3239.
38. Mortreux F, Leclercq I, Gabet AS, Leroy A, Westhof E, Gessain A, Wain-Hobson S, Wattel E. 2001. Somatic mutation in human T-cell leukemia virus type 1 provirus and flanking cellular sequences during clonal expansion in vivo. J Natl Cancer Inst 93:367-377.
39. + T cells in cerebrospinal fluid from patients with HAM/TSP. Ann Neurol 50:807-812.
40. Nicklas JA, O'Neill IP, Albertini RJ. 1986. Use of T-cell receptor gene probes to quantify the in vivo hprt mutations in human T. lymphocytes. Mutat Res 173:65-72.
41. O'Neill JP, McGinniss MJ, Berman JK, Sullivan LM, Nicklas JA, Albertini RJ. 1987. Refinement of a T-lymphocyte cloning assay to quantify the in vivo thioguanine-resistant mutant frequency in humans. Mutagenesis 2:87-94.
42. O'Neill JP, Nicklas JA, Hunter TC, Batson OB, Allegretta M, Falta MT, Branda RF, Albertini RJ. 1994. The effect of T-cell "clonality" on the calculated hprt mutation frequency occurring in vivo in humans. Mutat Res 313:215-225.
43. Osame M, Usuku K, Izumo S, Ijichi N, Amitani H, Igata A, Matsumoto M, Tara M. 1986. HTLV-I associated myelopathy, a new clinical entity. Lancet 1:1031-1032.
44. Robinson D, Goodall K, Albertini RJ, O'Neill JP, Finette B, Sala-Trepat M, Tates AD, Beare D, Green MHL, Cole J. 1994. An analysis of in vivo HPRT mutant frequency in circulating T lymphocytes in the normal human population: a comparison of four databases. Mutat Res 313:227-247.
45. Scheerer JP, Xi L, Knapp GW, Setzer RW, Bigbee WL, Fuscoe JC. 1999. Quantification of illegitimate V(D)J recombinase-mediated mutations in lymphocytes of newborns and adults. Mutat Res 431:291-303.
46. Sfikakis PP, Tesar J, Theocharis S, Klipple GL, Tsokos GC. 1994. Increased frequency of in vivo HPRT gene-mutated T cells in the peripheral blood of patients with systemic sclerosis. Ann Rheum Dis 53:122-127.
47. Theocharis S, Sfikakis PP, Lipnick RN, Klipple GL, Steinberg AD, Tsokos GC. 1995. Characterization of in vivo mutated T cell clones from patients with systemic lupus erythematosus. Clin Immunol Immunopathol 74:135-142.
48. Tonegawa S. 1983. Somatic generation of antibody diversity. Nature 302:575-581.
49. Tycko B, Sklar J. 1990. Chromosomal translocations in lymphoid neoplasia: a reappraisal of the recombinase model. Cancer Cells 2:1-8.
50. Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, Uchino H. 1977. Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood 50:481-492.
51. Uchiyama T. 1997. Human T cell leukemia virus type I (HTLV-I) and human diseases. Annu Rev Immunol 15:15-37.
52. Van den Berg LH, Mollee I, Wokke JH, Logtenberg T. 1995. Increased frequencies of HPRT mutant T lymphocytes in patients with Guillain-Barre syndrome and chronic inflammatory demyelinating polyneuropathy: further evidence for a role of T cells in the etiopathogenesis of peripheral demyelinating diseases. J Neuroimmunol 58:37-42.
53. Wilson VL, Wade KR, Yin X, Albertini RJ. 2001. Temporal delineation of sequential HPRT mutations arising in vivo in a T cell clone with a mutator phenotype. Mutat Res 473:181-199.
54. Wood GM, Dawisha S, Gourley M. 1994. Characteristics of HPRT-mutant T cell lines in a lupus patient treated with cyclophosphamide. Arthritis Rheum 37:1548-1552.